Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

RxSource Invests in Clinical Labelling Software to Enhance Service Offering

PRISYM 360 SaaS clinical trials system will help RxSource streamline its operations.

Global Clinical Trial

PRISYM ID, a provider of regulated content and label management systems, announces that Global Clinical Trial Supplies Specialist RxSource has invested in the innovative PRISYM 360 clinical labelling platform. The software is designed to enable RxSource to optimize its demand-led secondary packaging and labelling services, and supply medicines within as little as 48 hours, while ensuring regulatory compliance.

RxSource specializes in the ethical sourcing, packaging, and delivery of medicines for Clinical Trials, Research & Development, and Expanded Access Programs. They will now design and create labels in-house using the cloud-based PRISYM 360 clinical trials labelling system from PRISYM ID. 

RxSource has seen a rise in demand for its services during the pandemic as drug shortages and patient recruitment have proved problematic for many companies in the clinical trials sector. 

The PRISYM 360 platform is meant to optimize label management processes, allowing users to build up a library of approved language translations and automatically apply regulatory rules and intelligence to label content. This should reduce the complexity and time traditionally involved in clinical labelling.

PRISYM ID plans to support the life sciences sector’s need for more agility through the cloud-based version of its clinical trials labelling platform, including a pre-validated pack with industry standard print processes.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?